NHGRI Awards Geospiza $110K Grant to Develop Clinically Oriented Sequence Analysis Software | GenomeWeb

By Vivien Marx

Armed with a $110,000 Small Business Innovation Research grant from the National Human Genome Research Institute, Geospiza plans to collaborate with the Mayo Clinic to explore how to develop software systems that will push second-generation sequencing closer to use as a cancer diagnostics tool.

"The plan is to test the feasibility of developing new approaches to detecting sequence variants at low levels," Geospiza CEO Todd Smith told BioInform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.